Clinical Trial Update: Post- Myocardial Infarction Arterial Wall Improvement by Low-dose Fluvastatin and Valsartan [NA]

View source ↗

Summary

A completed clinical trial investigated whether low-dose fluvastatin plus valsartan improves arterial wall characteristics after myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• DIOVAN (valsartan)
• Lescol (fluvastatin)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Myocardial Infarction | NA | Status: COMPLETED